Etoposide pharmacokinetics impact the outcomes of lymphoma patients treated with BEAM regimen and ASCT: a multicenter study of the LYmphoma Study Association (LYSA)
Crossref DOI link: https://doi.org/10.1007/s00280-015-2866-9
Published Online: 2015-09-21
Published Print: 2015-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
You, Benoit
Salles, Gilles
Bachy, Emmanuel
Casasnovas, Olivier
Tilly, Hervé
Ribrag, Vincent
Sebban, Catherine
Hénin, Emilie
Guitton, Jéome
Tod, Michel
Freyer, Gilles
Text and Data Mining valid from 2015-09-21